Switch From Epzicom to Truvada Maintains HIV Suppression: StudySwitch From Epzicom to Truvada Maintains HIV Suppression: Study

Virologic suppression was maintained when HIV patients switched from lamivudine/abacavir (ABC/3TC) to emtricitibine/tenofovir (FTC/TDF) in the pharma-funded SWIFT study. Reuters Health Information
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Source Type: news

Related Links:

More News: Abacavir Sulfate and Lamivudine | Epzicom | Health | HIV AIDS | Infectious Diseases | Pharmaceuticals | Study | Truvada | Viread | Virology